Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the U.S. and worldwide. A new policy statement from the American Heart Association (AHA) provides a focused review of VTE, risk scoring systems, preventive measures for the hospital environment and tracking methods. The document was published recently in the journal Circulation.
Acute VTE is a frequent, costly complication in hospital settings, and a leading contributor to increased length of stay. The projected annual cost of preventable hospital-acquired VTE is $7–10 billion per year.
“This policy statement serves as a call to action to reduce incidents of VTE, a preventable disease and a major cause of death in hospitalized patients,” said the policy statement’s lead author, Peter K. Henke, MD, of the University of Michigan Medicine in Ann Arbor, Michigan.
He continued: “Standardized risk assessment and national tracking in hospitals are essential steps to prevent VTE in patients nationwide. The American Heart Association welcomes the opportunity to work with hospitals to ensure progress is made in reducing VTE, raising public awareness and providing support to patients and families.”
The AHA identifies five major areas of policy guidance that will lead to better implementation, tracking and prevention of VTE events. They include:
- Performing VTE risk assessment and reporting the level of VTE risk in all hospitalized patients
- Integrating ‘preventable VTE’ as a benchmark for hospital comparison and pay-for-performance programs
- Supporting appropriations to improve public awareness of VTE
- National tracking of VTE using standardized definitions
- Developing a centralized data registry for tracking on VTE risk assessment, prevention, and rates.
Most estimates place the U.S. annual incidence of diagnosed VTE in adults at one to two per 1000 per year, increasing with age, obesity, and in blacks. Preventive measures for reducing VTE in high-risk hospitalized medical and surgical patients are safe, clinically effective and cost-effective, but they are under-utilized.
The AHA policy statement concludes that increased VTE awareness and prioritization of proven, evidence-based primary prevention strategies accompanied by uniform tracking of hospital-acquired VTE should be a national health priority.
